Stock Movers

On this episode of Stock Movers:

- Hims & Hers (HIMS) shares fall on news that Novo Nordisk is suing the company for making knock-offs of its obesity medicines, including a copycat version of the Wegovy pill. The lawsuit targets not only Hims's copycat pill but also shots that mimic Novo's Wegovy and Ozempic, with Novo arguing that Hims's products are putting patient health and wellbeing at risk.

- Kroger (KR) shares rise after the company named Greg Foran its chief executive officer as the nation’s largest supermarket operator seeks to reset after a failed mega-merger and the sudden exit of its former leader.

- Monday.com (MNDY) shares sink after the software company’s revenue forecast was weaker than expected. According to Bloomberg Intelligence: Monday.com's below-consensus 2026 outlook reinforces our caution around seat-based business models amid slower AI-feature monetization, a shift toward agentic workflows and newer product rollouts from foundational model providers that increase the risk of disintermediation.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Alphabet Inc.(GOOGL) is tapping the US high-grade bond market, adding to a borrowing spree by companies at the forefront of the artificial intelligence investment boom.

- Hims & Hers Health (HIMS) tumbles 20% after the telehealth company said it will stop selling its recently launched copycat version of the new Wegovy weight-loss pill.

- Tegna Inc.(TGNA) rises 9% after President Donald Trump backed television broadcaster Nexstar Media Group’s proposed $3.5 billion acquisition of the company.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Hims & Hers Health (HIMS) shares tumble as much as 17% in premarket trading on Monday after the telehealth company said it will stop selling its recently-launched copycat version of the new Wegovy weight-loss pill.

- Eli Lilly & Co (LLY) agreed to buy closely held US biotech Orna Therapeutics Inc. for up $2.4 billion in cash, its second deal in as many days as the company expands its pipeline beyond its well-known blockbuster obesity drug Zepbound. Orna is developing a new class of treatments for certain autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. The biotech company, which is based in Watertown, Massachusetts, has struck licensing deals with other companies, including Vertex Pharmaceuticals Inc. and Merck & Co.

- Alphabet (GOOG) is looking to raise about $15 billion from a US high-grade dollar bond sale, according to people with knowledge of the matter, adding to a borrowing spree by companies at the forefront of the artificial intelligence investment boom.Massive cloud-computing companies known as hyperscalers are expected to spend more than $650 billion this year to expand AI infrastructure. Since last year, the group has flooded the market with debt that investors have so far eagerly absorbed, although concerns are growing that excessive spending on AI may be fueling a bubble.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Hims & Hers Health (HIMS) shares tumble after the telehealth company said it will stop selling its recently-launched copycat version of the new Wegovy weight-loss pill.
- Kroger (KR) plans to name Greg Foran as the supermarket chain’s next chief executive officer, according to a person familiar with the matter, as the nation’s largest grocer looks to carve a new path after a failed megadeal and an unexpected exit of its former boss. Kroger replaced CEO Rodney McMullen in March after an investigation into his personal conduct, which followed a failed $24.6 billion merger with Albertsons Cos. that was blocked on antitrust grounds. The company didn’t specify the nature of his conduct.
- STMicro (STM) shares rise as much as 6.5% to the highest since October after the chipmaker said it’s expanding collaboration with Amazon’s AWS, an agreement that analysts say will help increase exposure to the fast-growing AI data center market.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Novo Nordisk shares surged, reversing some of last week’s plunge, after Hims & Hers Health Inc. pulled a copycat version of the new Wegovy weight-loss pill.
- Greggs shares drop as much as 6%, touching the lowest in more than two months, after Jefferies downgraded the bakery chain to hold, and cut its price target by more than a third, noting that the uptake of weight-loss drugs was a headwind to the earnings outlook.
- UniCredit SpA plans to return about €50 billion ($59 billion) to investors through 2030 as Chief Executive Officer Andrea Orcel vows to further improve profitability and capital generation over the next five years.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Novo Nordisk shares surged, reversing some of last week’s plunge, after Hims & Hers Health Inc. pulled a copycat version of the new Wegovy weight-loss pill.
- NatWest Group Plc agreed to buy wealth manager Evelyn Partners, as the British bank looks to increase its access to affluent clients in its home market.
- Investors led by buyout firm Advent International LP and FedEx Corp. agreed to buy Polish parcel-locker company InPost SA in a deal that values the business at €7.8 billion

See omnystudio.com/listener for privacy information.

Big Tech earnings are still in focus with Cisco, McDonalds, and T-Mobile all reporting in the coming days.
Bloomberg's Nathan Hager previews the numbers with Bailey Lipschultz, Bloomberg News Senior Equities Reporter

See omnystudio.com/listener for privacy information.

This week's biggest winners and losers in the stock market.

On this episode of Stock Movers:

• Amazon (AMZN) shares ended the week lower after the company announced plans to spend $200 billion this year on data centers, chips and other equipment, worrying investors that its colossal bet on artificial intelligence may not pay off in the long run. The company reported spending roughly $130 billion on property and equipment in 2025. Analysts anticipated those expenses would reach about $150 billion this year. Chief Executive Officer Andy Jassy said the money “predominantly” would go toward the company’s Amazon Web Services cloud unit, and most of that spending would be for AI workloads.
• Coinbase (COIN) shares dropped this week with trading volume dragged down by weakening Bitcoin and Ethereum values. The platform’s “Everything Exchange” plans — which would see it combine prediction-markets trading along with metals futures offerings on its core crypto platform — will be key for its 2026 prospects, BI said.
• Tapestry (TPR) shares rose this week after the maker of the Coach brand boosted its adjusted earnings per share guidance for the full year. The improved outlook beat the average analyst estimate.

See omnystudio.com/listener for privacy information.

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.

• Robinhood (HOOD) and Strategy (MSTR) shares rose as the price of cryptocurrencies broadly rebounded. Robinhood generates a significant portion of its revenue from crypto trading. Bitcoin surged the most in almost three years to recoup almost all of the losses registered during Thursday’s crypto market meltdown that had dragged the token down more than 50% from its October peak.
• Under Armour (UA) shares ended the day higher after the athletic apparel and footwear company surprised investors with a quarter profit. Revenue were also slightly above the consensus estimate. Management boosted its adjusted EPS estimate. 
• Amazon (AMZN) ended the day lower. Shares posted at 12% weekly decline, the most since 2022, after the e-commerce and cloud-computing company’s much higher-than-expected $200 billion annual capital spending forecast underlined concerns on how much big tech companies are spending on AI-related investments and when they will pay off.
• Molina Healthcare (MOH) shares plunged after the health insurer forecast 2026 profit that was less than half of Wall Street’s expectations, on higher medical costs and insufficient government repayments.
• Homebuilders (S5HOME Index) declined Friday on the news Trump administration officials are exploring opening an antitrust investigation into US homebuilders as the White House sharpens its focus on tackling the country’s housing affordability crisis.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

Amazon (AMZN) shares fall after the company announced plans to spend $200 billion this year on data centers, chips and other equipment, worrying investors that its colossal bet on artificial intelligence may not pay off in the long run.The company reported spending roughly $130 billion on property and equipment in 2025. Analysts anticipated those expenses would reach about $150 billion this year.

Strategy (MSTR) shares rise, along with other crypto companies, after bitcoin surged the most in almost three years to recoup almost all of the losses registered during Thursday’s crypto market meltdown that had dragged the token down more than 50% from its October peak. The dizzying swings of around 13% have helped to reignite a jump in the volatility that traders traditionally relish because of the potential profit opportunities.

 
Coty (COTY) shares plunge after the distributor of beauty products forecasts for third quarter adjusted Ebitda and like-for-like sales were well short of the consensus estimates. Annual guidance was withdrawn, with the company citing a “complex beauty market backdrop,” as well as its leadership transition.

See omnystudio.com/listener for privacy information.